GSK (GSK) RNS Announcements

Add to Alert list
Date Time Source Announcement
21 Jul 2014 05:38 PM
RNS
Director/PDMR Shareholding
18 Jul 2014 04:27 PM
RNS
Director/PDMR Shareholding
18 Jul 2014 04:25 PM
RNS
Director/PDMR Shareholding
18 Jul 2014 04:24 PM
RNS
Director/PDMR Shareholding
17 Jul 2014 02:00 PM
RNS
MEK/BRAF combination phase III study update
16 Jul 2014 04:59 PM
RNS
Director/PDMR Shareholding
16 Jul 2014 07:00 AM
RNS
Start of phase III study - FF/UMEC/VI combination
14 Jul 2014 04:11 PM
RNS
Director/PDMR Shareholding
14 Jul 2014 04:11 PM
RNS
Director/PDMR Shareholding
11 Jul 2014 05:07 PM
RNS
Director/PDMR Shareholding
11 Jul 2014 05:05 PM
RNS
Director/PDMR Shareholding
11 Jul 2014 05:03 PM
RNS
Director/PDMR Shareholding
10 Jul 2014 04:37 PM
RNS
Director/PDMR Shareholding
10 Jul 2014 04:23 PM
RNS
Director/PDMR Shareholding
10 Jul 2014 04:18 PM
RNS
Director/PDMR Shareholding
08 Jul 2014 03:57 PM
RNS
Director/PDMR Shareholding
07 Jul 2014 05:00 PM
RNS
Director/PDMR Shareholding
02 Jul 2014 03:11 PM
RNS
Director/PDMR Shareholding
01 Jul 2014 10:53 AM
RNS
Total Voting Rights
30 Jun 2014 05:17 PM
RNS
Director/PDMR Shareholding
30 Jun 2014 01:00 PM
RNS
Breo Ellipta US regulatory submission
27 Jun 2014 12:42 PM
RNS
Triumeq receives positive CHMP opinion
24 Jun 2014 05:30 PM
RNS
Transaction in Own Shares
23 Jun 2014 05:14 PM
RNS
Director/PDMR Shareholding
17 Jun 2014 04:55 PM
RNS
Transaction in Own Shares
16 Jun 2014 05:20 PM
RNS
Transaction in Own Shares
13 Jun 2014 05:46 PM
RNS
Transaction in Own Shares
13 Jun 2014 02:03 PM
RNS
Director/PDMR Shareholding
12 Jun 2014 04:54 PM
RNS
Transaction in Own Shares
11 Jun 2014 05:36 PM
RNS
Transaction in Own Shares
11 Jun 2014 03:53 PM
RNS
Director/PDMR Shareholding
11 Jun 2014 03:50 PM
RNS
Director/PDMR Shareholding
11 Jun 2014 12:30 PM
RNS
Incruse Ellipta positive data studies
09 Jun 2014 06:01 PM
RNS
Director/PDMR Shareholding
09 Jun 2014 05:45 PM
RNS
Transaction in Own Shares
06 Jun 2014 04:55 PM
RNS
Transaction in Own Shares
05 Jun 2014 05:34 PM
RNS
Transaction in Own Shares
05 Jun 2014 03:55 PM
RNS
Director/PDMR Shareholding
04 Jun 2014 05:23 PM
RNS
Transaction in Own Shares
03 Jun 2014 05:39 PM
RNS
Transaction in Own Shares
02 Jun 2014 05:33 PM
RNS
Transaction in Own Shares
02 Jun 2014 02:02 PM
RNS
Total Voting Rights
30 May 2014 05:34 PM
RNS
Transaction in Own Shares
29 May 2014 06:19 PM
RNS
Transaction in Own Shares
28 May 2014 05:30 PM
RNS
Transaction in Own Shares
28 May 2014 07:00 AM
RNS
Serious Fraud Office Investigation
27 May 2014 05:40 PM
RNS
Transaction in Own Shares
27 May 2014 05:32 PM
RNS
Director/PDMR Shareholding
23 May 2014 04:59 PM
RNS
Transaction in Own Shares
21 May 2014 05:40 PM
RNS
Transaction in Own Shares

GSK PLC, known as GSK, is a renowned multinational pharmaceutical and biotechnology company with its global headquarters in London. Traded as GSK on the London Stock Exchange (LSE), it has a rich history that traces back to the establishment of Plough Court Pharmacy in London in 1715. Over the centuries, GSK has grown from a handful of individual founders into a company of over 69,000 people.

The company's journey includes the development of 15 first-in-class or combination vaccines and pioneering medications in respiratory, antibiotics, antivirals, and oncology. GSK has been a leader in medicines that advance the management of asthma and chronic obstructive pulmonary disease (COPD) for 50 years.

In 2000, Glaxo Wellcome and SmithKline Beecham merged to form the modern GSK, becoming a key player on the LSEG. Today, GSK continues to shape the global healthcare landscape, committed to defeating diseases that impact people's health. This evergreen company remains at the forefront of the pharmaceutical industry, embodying its founding principle of improving the quality of human life by enabling people to do more, feel better, and live longer.

GSK share price launched at 346p in 1989. 

UK 100

Latest directors dealings